Month: July 2021
DNA PLC STOCK EXCHANGE RELEASE 19 JULY 2021, 15:00 EEST
Ville Virtanen, BEng, EMBA, has been named DNA Plc’s Chief Technology Officer (CTO) and a member of the Executive Team.
Ville Virtanen, 45, will start in his new position on 1 September 2021. He is taking up the post after acting as the VP of DNA’s Core and IP Networks department. Virtanen has been at DNA since 2003 and has been broadly responsible for the services of DNA’s mobile and fixed networks, as well as its business-critical service platforms. Before joining DNA, Ville held a number of positions related to the development of networks and IT services at Telia.
In his new role, Virtanen will be responsible for DNA’s various network technologies and their development. He reports to the CEO of DNA. Virtanen succeeds Tommy Olenius, who will be continuing in the position until the...
ContraFect Announces Multiple Presentations of New Research Data From Its Pipeline of Direct Lytic Agents at the 31st ECCMID
Written by Customer Service on . Posted in Public Companies.
YONKERS, N.Y., July 19, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced multiple presentations, including two oral presentations, of data from its portfolio of DLAs from the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), now available online.
“The data presented at ECCMID further illustrates the potential utility of our lysin therapeutic modalities to address important unmet medical needs. Our new in vitro data suggests that our lead lysin, exebacase, currently in Phase 3 with Breakthrough therapy designation for...
Allied Joins Jesta Group in Completing Iconic Place Gare Viger Project in Montréal
Written by Customer Service on . Posted in Public Companies.
TORONTO, July 19, 2021 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today that it will acquire the urban office component of Jesta Group’s Place Gare Viger in Montréal. Place Gare Viger is an exceptional mixed-use development located at the intersection of Old Montréal, Viger Square and the recently completed Centre Hospitalier de l’Université de Montréal (CHUM). Over the last decade, Jesta Group has transformed Gare Viger, one of the finest heritage properties in Canada, into a distinctive urban office, residential and hotel complex. Allied has entered into an agreement with Jesta Group to acquire the urban office component of the complex. Jesta Group will retain the urban residential and hotel components of the complex.
Allied and Jesta Group were brought together by...
Trailbreaker Resources Completes Phase 1 Exploration at the Atsutla Gold Project, Mobilizes to Skelly
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to announce completion of the Phase 1 exploration program at its 100%-owned Atsutla Gold project, located in northwestern British Columbia (BC). Trailbreaker will also conduct an exploration program at its 100%-owned Skelly property in 2021.
The Atsutla Gold project covers over 23,000 hectares and is located 70 km south of the Yukon-BC border and 130 km northwest of the community of Dease Lake, BC.
The Phase 1 exploration program involved the collection of 1,680 soil samples and 295 prospecting grab samples, as well as geological mapping. Efforts were focused on follow-up of the high-grade gold, silver, and copper discoveries made at the Willie Jack property in 2020 (see below for further...
AdvanceTC Announces US$3.015 Billion Valuation
Written by Customer Service on . Posted in Public Companies.
NEW YORK, NY, July 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AdvanceTC Limited (NSX:A88,OTCQB:ATCLF) (“AdvanceTC” or the “Company”) is pleased to announce that we have appointed a professional valuer, Roma Appraisals Limited (the “Valuer”), to conduct a valuation of the Company as of 26th May 2021. The valuation report (“Valuation Report”) dated 16th July 2021 stated the Company’s market value was approximately USD3.015 Billion as at 26th May 2021. The valuation is based on an income approach and discounted cash-flow model.
The Company would like to take this opportunity to thank and congratulate all its stakeholders on achieving this milestone. The report will be available on the Company’s website this week; please find below the report link.https://backend.otcmarkets.com/otcapi/company/financial-report/291793/content
About...
Medexus Appoints New Chief Financial Officer
Written by Customer Service on . Posted in Public Companies.
TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad as Chief Financial Officer of the Company, effective immediately. Mr. Konrad succeeds Roland Boivin, who is stepping down after nearly a decade in the role. Mr. Boivin has agreed to stay on in an advisory capacity in order to help ensure an orderly transition of responsibilities to Mr. Konrad over the next approximately three months.
“I want to take this opportunity on behalf of all of us at Medexus to thank Roland for all of his efforts and dedicated service and to wish him the very best in his future endeavours,” said Ken d’Entremont, the Company’s Chief Executive Officer.
“I am grateful for the opportunity to have worked with the entire...
Cytokinetics Announces Positive Topline Results of Redwood-HCM
Written by Customer Service on . Posted in Public Companies.
Figure 1Resting LVOT-GFigure 2Valsalva LVOT-GPhase 2 Clinical Trial of CK-274 Demonstrated Consistent and Clinically Meaningful Reductions in Left Ventricular Outflow Tract Gradients Within Two Weeks in Patients with Obstructive Hypertrophic Cardiomyopathy
No Treatment Interruptions or Discontinuations Due to Reduction in Left Ventricular Ejection Fraction
Phase 3 Registrational Trial of CK-274 Expected to Start Before Year End
Company to Host Conference Call and Webcast Today at 8:30 a.m. Eastern Time
SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from Cohorts 1 and 2 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), the Phase 2 clinical trial of...
Aleafia Health Launches Premium Cannabis Brand Nith & Grand
Written by Customer Service on . Posted in Public Companies.
Nith & Grand tailored to cannabis aficionados with discerning taste, and will feature craft flower and premium concentrates
Initial launch features TF Pink Kush Live Resin vape cartridges
Strengthened product portfolio contributing to meaningful quarterly sales growth across all sales channelsTORONTO, July 19, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its premium cannabis brand Nith & Grand. Featuring hang dried, hand trimmed, small batch dried flower, and premium concentrates, Nith & Grand appeals to experienced cannabis aficionados.
The initial launch features TF Pink Kush Live Resin vape cartridges, which comprises a hydrocarbon extraction process utilizing fresh-frozen cannabis flower that preserves the strain’s...
California’s NCTD exercises options to add 50 more NFI low-emission Xcelsior CNG buses in North San Diego
Written by Customer Service on . Posted in Public Companies.
WINNIPEG, Manitoba, July 19, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF) — NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that the North County Transit District (“NCTD”) has recently exercised options for 50 New Flyer of America Inc. (“New Flyer”) Xcelsior® compressed natural gas (“CNG”) forty-foot, heavy-duty transit buses, converted from backlog. The first option conversion occurred in 2020 with 20 buses ordered, with the remaining 30 ordered in 2021.
The options are part of a five-year contract with NCTD established in 2016 for up to 103 Xcelsior® CNG thirty-five or forty-foot buses. The order, supported by Federal Transit Administration funds, replaces older, end-of-life vehicles with lower-emission and more...
Ayr Wellness Agrees to Acquire Tahoe Hydro, Adding Award-Winning Cultivators of High-Quality Flower in Nevada
Written by Customer Service on . Posted in Mergers And Acquisitions.
NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator (“MSO”), has announced a Definitive Purchase Agreement (the “Purchase Agreement”) to acquire Tahoe Hydroponics Company, LLC (“Tahoe Hydro”), an award-winning cultivator and one of Nevada’s top producers of high-quality cannabis flower, and NV Green, Inc. (“NV Green”), producers of best-in-class concentrates. The transaction is subject to customary regulatory and other approvals.
Tahoe Hydro operates ~33,000 square feet of total cultivation and manufacturing space in its facilities in Carson City, Nevada, and Sparks, Nevada. It grows flower and produces concentrates for some of the state’s top selling brands, including Tahoe Hydro and LIT (Lost in Translation),...
